Company: VRCA
Filing Date: 2025-03-11
Form Type: 10-K
Source: 0000950170-25-037172
Chunk: 207

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-03-11
Form: 10-K
Item: Item 1B
Chunk 207
---
-K of Verrica Pharmaceuticals Inc., and any or all amendments thereto, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises hereby ratifying and confirming all that said attorneys-in-fact and agents, or his, her or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

    Signature
      
    Title
      
             Date

    /s/ Jayson RiegerJayson Rieger
     
    President, Chief Executive Officer and Director (Principal Executive Officer)

     March 11, 2025

    /s/ John J. KirbyJohn J. Kirby
     
    Interim Chief Financial Officer(Interim Principal Financial Officer and Interim Principal Accounting Officer)

     March 11, 2025

    /s/ Paul B. Manning Paul B. Manning
     
     Chairman of the Board of Directors

     March 11, 2025

    /s/ Sean StalfortSean Stalfort
     
     Director

     March 11, 2025

    /s/ Mark PrygockiMark Prygocki
     
    Director

    March 11, 2025

    /s/ Lawrence EichenfieldLawrence Eichenfield
     
    Director

    March 11, 2025

     /s/ Diem Nguyen

    Diem Nguyen
     
    Director

    March 11, 2025

127